OCT 02, 2019 7:41 AM PDT

Triple Drug Combo Extends Fruit Fly Lifespan

WRITTEN BY: Nouran Amin

A study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that a triple drug combination can extend the lifespan of a fruit fly (Drosphila) by 48%. "As life expectancy increase, we are also seeing an increase of age-related diseases so there is an urgent need to find ways to improve health in old age," said the study's co-lead author, Dr. Jorge Castillo-Quan, who began the research at the UCL Institute of Healthy Ageing before moving to Joslin Diabetes Center, Harvard Medical School.

Learn more about the Drosophila life cycle:

These drugs include lithium as a mood stabilizer, trametinib used for cancer treatment and rapamycin used to regulate the immune system—all of which act on different cellular ageing pathways. Decision upon choosing these drugs were a result of preliminary evidence in mice, worms, and cells, and observational findings in people.

"Here, by studying fruit flies which age much more rapidly than people, we have found that a combination drug treatment targeting different cellular processes may be an effective way to slow down the ageing process,” adds Dr. Castillo-Quan. "Previous studies in fruit flies have achieved lifespan extensions of about 5-20%, so we found it was quite remarkable that this drug combination enabled them to live 48% longer.”

Findings showed, that in particular, rapamycin has undesirable effects on fat metabolism which is similar to insulin resistance in people. However, lithium has cancelled out these effects when these two drugs were given together.

"There is a growing body of evidence that polypills -- pills that combine low doses of multiple pharmaceutical products -- could be effective as a medication to prevent age-related diseases, given the complex nature of the ageing process. This may be possible by combining the drugs we're investigating with other promising drugs, but there is a long way to go before we will be able to roll out effective treatments,” says principal investigator and Professor Linda Partridge (UCL Institute of Health Ageing and Max Planck Institute for Biology of Ageing).

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 09, 2020
Cancer
MAY 09, 2020
Examining a Combination Therapy Against Gastric Cancer
Often when it comes to treatments for cancer, designing or discovering new leads can take years. One of the common pract ...
MAY 08, 2020
Drug Discovery & Development
MAY 08, 2020
Cholesterol Drugs May Boost Healthy Gut Bacteria in Obese People
While statins have long been known for their efficacy in treating high cholesterol, until recently, there was no evidenc ...
MAY 10, 2020
Drug Discovery & Development
MAY 10, 2020
Antiviral Drug Treats Naso-Pharyngeal Cancer
Scientists at Hong Kong Baptist University (HKBU) developed a novel anti-Epstein-Barr virus (EBV) drug that can shrink t ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Approved Treatment for RET-mutant Cancers
A drug was recently approved for treating three types of RET-mutant cancers: 1) non-small cell lung cancer (NSCLC) 2) ad ...
JUN 25, 2020
Cell & Molecular Biology
JUN 25, 2020
Peptide Made by Marine Worms Can Destroy Multidrug-Resistant Bacteria
Drug-resistant bacteria pose a serious threat to public health, and scientists have been searching for new antibiotics t ...
JUL 02, 2020
Cannabis Sciences
JUL 02, 2020
What is the Difference Between CBD and CBG?
Like cannabidiol (CBD), cannabigerol (CBG) is a cannabinoid. Both compounds are found in cannabis plants. Both are also ...
Loading Comments...